Literature DB >> 2539356

Nucleotide sequences required for Tn3 transposition immunity.

J A Kans1, M J Casadaban.   

Abstract

The Tn3 transposon inserts at a reduced frequency into a plasmid already containing a copy of Tn3, a phenomenon known as transposition immunity. The cis-acting site on Tn3 responsible for immunity was mapped by deletions from each side to be within the terminal 38-base-pair sequence that is inversely repeated at the ends of Tn3. Two palindromic sequences are present in the essential part of this region. Some deletions conferred only partial immunity, and others conferred negative immunity. Multiple copies of partially immune ends conferred additional immunity. No other part of Tn3 was necessary for immunity.

Mesh:

Substances:

Year:  1989        PMID: 2539356      PMCID: PMC209839          DOI: 10.1128/jb.171.4.1904-1914.1989

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  57 in total

1.  Binding of the Tn3 transposase to the inverted repeats of Tn3.

Authors:  J H New; A K Eggleston; M Fennewald
Journal:  J Mol Biol       Date:  1988-06-05       Impact factor: 5.469

2.  The role of TnA transposase in transposition immunity.

Authors:  J Heritage; P M Bennett
Journal:  Plasmid       Date:  1984-11       Impact factor: 3.466

3.  Transposon Tn1 intra-molecular transposition.

Authors:  R Bishop; D Sherratt
Journal:  Mol Gen Genet       Date:  1984

4.  The location of sequences of TnA required for the establishment of transposition immunity.

Authors:  L J Wallace; J M Ward; M H Richmond
Journal:  Mol Gen Genet       Date:  1981

5.  Intermolecular and intramolecular transposition and transposition immunity in Tn3 and Tn2660.

Authors:  S J Chiang; E Jordan; R C Clowes
Journal:  Mol Gen Genet       Date:  1982

6.  p lambda CM system: observations on the roles of transposable elements in formation and breakdown of plasmids derived from bacteriophage lambda replicons.

Authors:  C J Muster; L A MacHattie; J A Shapiro
Journal:  J Bacteriol       Date:  1983-02       Impact factor: 3.490

7.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

8.  Identification of a transposon Tn3 sequence required for transposition immunity.

Authors:  C H Lee; A Bhagwat; F Heffron
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  New versatile plasmid vectors for expression of hybrid proteins coded by a cloned gene fused to lacZ gene sequences encoding an enzymatically active carboxy-terminal portion of beta-galactosidase.

Authors:  S K Shapira; J Chou; F V Richaud; M J Casadaban
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

10.  Transposition and transposition immunity of transposon Tn3 derivatives having different ends.

Authors:  A Arthur; E Nimmo; S Hettle; D Sherratt
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  5 in total

1.  DNA binding activities of the Caenorhabditis elegans Tc3 transposase.

Authors:  S D Colloms; H G van Luenen; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

2.  Conduction of pEC22, a plasmid coding for MR.EcoT22I, mediated by a resident Tn3-like transposon, Tn5396.

Authors:  J Elhai; Y Cai; C P Wolk
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

3.  Conversion of pBR322-based plasmids into broad-host-range vectors by using the Tn3 transposition mechanism.

Authors:  M Kok; M Rekik; B Witholt; S Harayama
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

4.  Uncoupling of transpositional immunity from gamma delta transposition by a mutation at the end of gamma delta.

Authors:  L A Wiater; N D Grindley
Journal:  J Bacteriol       Date:  1990-09       Impact factor: 3.490

5.  Binding of the IS903 transposase to its inverted repeat in vitro.

Authors:  K M Derbyshire; N D Grindley
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.